Saintmed Public Company Limited (SET: SMD) has announced its 3Q24 consolidated financial statement through the Stock Exchange of Thailand as follows:
SMD reported a net profit of THB 29.08 million, an increase of THB 16.84 million or 137.58% YoY. The increase was mainly due to the acceleration of government budget disbursements in the first and second quarters of 2024, resulting in returning product orders.
In Q3/2024, the company had a revenue from sales and services of THB 252.27 million, an increase of THB 69.34 million, or 37.91%, from the same period last year (YoY). The majority of the revenue came from government customers, accounting for 6 7.2 7% of the total. The increase in revenue was due to the accelerated disbursement of the 2024 government budget.
The company’s gross profit margin in Q3/2024 was 38.85%, compared to 34.90% in Q3/2023. The company’s net profit margin for Q3/2024 was 11.53%, an increase from 6.69% in Q3/2023, due to the growth in sales, which led to a higher net profit margin.
Additionally, the Company had a foreign exchange gain of THB 2.39 million, compared to a foreign exchange loss of THB 0.56 million in Q3/2023.
The Board of Directors have approved a dividend payment of THB0.50 per share to be paid on 12 December 2024. The ex-dividend date is 26 November 2024. This represents a 12.19% dividend yield when compared to the closing share price of THB4.10 per share on November 13.
